Matches in UGent Biblio for { <https://biblio.ugent.be/publication/744152#aggregation> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B333692.
- aggregation creator B333693.
- aggregation creator B333694.
- aggregation creator B333695.
- aggregation creator B333696.
- aggregation creator B333697.
- aggregation creator B333698.
- aggregation date "2007".
- aggregation format "application/pdf".
- aggregation hasFormat 744152.bibtex.
- aggregation hasFormat 744152.csv.
- aggregation hasFormat 744152.dc.
- aggregation hasFormat 744152.didl.
- aggregation hasFormat 744152.doc.
- aggregation hasFormat 744152.json.
- aggregation hasFormat 744152.mets.
- aggregation hasFormat 744152.mods.
- aggregation hasFormat 744152.rdf.
- aggregation hasFormat 744152.ris.
- aggregation hasFormat 744152.txt.
- aggregation hasFormat 744152.xls.
- aggregation hasFormat 744152.yaml.
- aggregation isPartOf urn:issn:0804-4643.
- aggregation language "eng".
- aggregation title "AcroBel - the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects".
- aggregation abstract "Objectives: To constitute a registry on acromegaly, AcroBel, to evaluate the epidemiology and quality of care of acromegaly in Belgium and Luxembourg. Design: A nationwide survey from June 2003 till September 2004 aiming to collect data from all patients with acromegaly who had visited the participating endocrine clinics after 1 January 2000. Methods: Retrospective data collection coupled to a visit within the survey period, allowing sampling of metabolic parameters and centralised determination of GH and IGF-1. Results: Four hundred and eighteen patients (51% men) were included, of which 96 were new cases, giving a mean incidence of 1.9 cases per million (c.p.m.) per year. The global prevalence was 41, c.p.m. but varied between 21 and 61 among different areas. Twenty-eight deaths were reported at a median age of 68 years in men and 74 years in women. The standardised mortality rate was significantly increased only in irradiated patients (2.70; confidence interval 1.60-4.55). Central measurements were available in 316 (75%,) patients. Mean GH was <= 2 mu g/l in 65%, and IGF-1 was normal for age in 56%, while both criteria were fulfilled in 49%,. Multimodal treatment was more effective than primary medical therapy, since 56.5% were controlled versus 24.3%) (P < 0.0001.). Conclusions: AcroBel provides an excellent tool to analyse the prevalence, incidence, treatment modalities and outcome of acromegaly in Belgium. This real-life survey reveals that only half of acromegalic patients received an adequate therapy resulting in cure or disease control when stringent biochemical criteria are used.".
- aggregation authorList BK628898.
- aggregation endPage "409".
- aggregation issue "4".
- aggregation startPage "399".
- aggregation volume "157".
- aggregation aggregates 768260.
- aggregation isDescribedBy 744152.
- aggregation similarTo EJE-07-0358.
- aggregation similarTo LU-744152.